Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 178,880 | 120,820 | 90,180 | 73,290 | 47,890 |
| Depreciation Amortization | 44,000 | 31,310 | 14,590 | 7,110 | 5,243 |
| Other Working Capital | -69,360 | -57,650 | 4,710 | -10,780 | -4,663 |
| Other Operating Activity | -30,290 | 23,250 | -12,410 | 32,010 | -13,077 |
| Operating Cash Flow | $123,230 | $117,730 | $97,070 | $101,630 | $35,393 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26,770 | -26,460 | -13,640 | -9,740 | -21,125 |
| Net Acquisitions | -105,820 | -71,550 | -15,300 | -18,730 | 0 |
| Other Investing Activity | 67,060 | -182,840 | -101,870 | -21,730 | 765 |
| Investing Cash Flow | $-65,530 | $-280,850 | $-130,810 | $-50,200 | $-20,360 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -15,300 | 126,010 | -41,640 | 4,580 | 6,016 |
| Financing Cash Flow | $-15,300 | $126,010 | $-41,640 | $4,580 | $6,016 |
| Beginning Cash Position | 59,660 | 82,830 | 158,220 | 92,210 | 71,165 |
| End Cash Position | 102,050 | 45,720 | 82,830 | 148,230 | 92,214 |
| Net Cash Flow | $42,390 | $-37,100 | $-75,380 | $56,010 | $21,049 |
| Free Cash Flow | |||||
| Operating Cash Flow | 123,230 | 117,730 | 97,070 | 101,630 | 35,393 |
| Free Cash Flow | 123,230 | 117,730 | 97,070 | 101,630 | 35,393 |